Characterization of Major and Clinically Relevant Non-Major Bleeds in the APEX Trial

Background  Among medically ill patients treated with thromboprophylaxis, betrixaban was not associated with an increase in major bleeding compared with enoxaparin, but an increase in clinically relevant non-major (CRNM) bleeding was observed. The aim of this analysis is to describe the severity and...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:TH Open
Prif Awduron: Yee, Megan K., Gibson, C. Michael, Nafee, Tarek, Kerneis, Mathieu, Daaboul, Yazan, Korjian, Serge, Chi, Gerald, AlKhalfan, Fahad, Hernandez, Adrian F., Hull, Russell D., Cohen, Alexander T., Goldhaber, Samuel Z.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Georg Thieme Verlag KG 2019
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6524922/
https://ncbi.nlm.nih.gov/pubmed/31249989
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1055/s-0039-1685496
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg